Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...
Eli Lilly just gave investors several reasons to cheer.
Eli Lilly And Co. LLY, a top pick for the firm, is projected to see continued growth in its diabetes and obesity ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks Jim Cramer talked about this week. Jim Cramer, host of Mad Money, recently ...
Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...
Eli Lilly and Company (NYSE: LLY) today announced that the National Medical Products Administration (NMPA) in China has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL every four weeks injection ...
The updates from clinical trials of Eli Lilly's competitors in the obesity market were largely underwhelming this year. See ...
As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.
As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Akash Tewari has given his Buy rating due to a combination of factors including Eli Lilly & Co’s strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback